HCGMCC Introduces Vansham Clinic to Promote Hereditary Cancer Awareness and Provide Lifesaving Family Screenings
WHO Updates Cervical Cancer Guidelines to Incorporate Roche’s Dual-Stain Test
AdvancedDx Biological Laboratories and Complete Genomics Form Partnership for NGS-Based Infectious Disease Assays
MOC Cancer Care & Research Centre Unveils CAR-T Cell Therapy
CJI Calls for Universal Access to Gene Therapy
Quad Cancer Moonshot: A United Effort to Eliminate Cervical Cancer in the Indo-Pacific
ICGA Launches India's First Open-Access Cancer Data Portal to Advance Personalized Treatment
Redcliffe Labs Introduces Gut Microbiome and HealthEx Tests to Enhance Preventive Healthcare
New Novartis Data Highlight Kesimpta® Benefits for First-Line and Switch Patients in Relapsing Multiple Sclerosis
IMAC Holdings Inc. Unveils Ignite Proteomics Subsidiary and Introduces Innovative Precision Oncology Case Study Featuring RPPA Technology
CS Genetics and ROSALIND® Join Forces to Expand Access to Single-Cell Genomics
Neuberg Diagnostics Unveils Geniee: A Personalized Genomics Platform
GE HealthCare's MIM Software Receives FDA Clearance for New Centiloid Scaling Tool to Quantify Amyloid Plaque in Brain Imaging
FDA Approves Merck's KEYTRUDA® (Pembrolizumab) in Combination with Pemetrexed and Platinum Chemotherapy as a First-Line Treatment for Adults with Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM)
OncoLens Introduces Real-Time Oncology Patient Identification for Clinical Trials and Essential Services